Atlas Trials

Leptin: A Marker for AML Chemo-Sensitivity

Clinical trial NCT07163728 · RECRUITING

Trial details

NCT number
NCT07163728
Sponsor
Fujian Medical University Union Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
AMLAdult
Start date
2025-08-01
Primary completion
2026-06-30
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.